Drug Profile
Research programme: cell-based influenza virus vaccines - Johnson & Johnson Innovative Medicine
Alternative Names: FluCell; FluCell - Plus (Seasonal Plus); UniFluLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Crucell
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 01 Oct 2023 In October 2023, Janssen Pharmaceuticals changed its name to Johnson & Johnson Innovative Medicine (Janssen Pharmaceuticals website, October 2023).
- 16 Jul 2016 No recent reports of development identified for preclinical development in Influenza-virus-infections(Prevention) in Netherlands (Parenteral)
- 06 Sep 2013 Isconova is now called Novavax AB